Literature DB >> 31056712

Serum dickkopf-related protein 1 and sclerostin may predict the progression of chronic kidney disease in Japanese patients.

Kazu Hamada-Ode1, Yoshinori Taniguchi1, Yoshiko Shimamura1, Shimpei Fujimoto1, Yoshio Terada1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31056712     DOI: 10.1093/ndt/gfz078

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

Review 1.  New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1).

Authors:  Aylin Sepinci Dincel; Niklas Rye Jørgensen
Journal:  Calcif Tissue Int       Date:  2022-09-27       Impact factor: 4.000

Review 2.  Research progress on the relationship between IS and kidney disease and its complications.

Authors:  Yan Gao; Ye Li; Xueting Duan; Qian Wang; Haisong Zhang
Journal:  Int Urol Nephrol       Date:  2022-04-29       Impact factor: 2.266

Review 3.  Secondary Osteoporosis and Metabolic Bone Diseases.

Authors:  Mahmoud M Sobh; Mohamed Abdalbary; Sherouk Elnagar; Eman Nagy; Nehal Elshabrawy; Mostafa Abdelsalam; Kamyar Asadipooya; Amr El-Husseini
Journal:  J Clin Med       Date:  2022-04-24       Impact factor: 4.964

4.  Inflammation-Related Patterns in the Clinical Staging and Severity Assessment of Chronic Kidney Disease.

Authors:  Simona Mihai; Elena Codrici; Ionela D Popescu; Ana-Maria Enciu; Elena Rusu; Diana Zilisteanu; Laura G Necula; Gabriela Anton; Cristiana Tanase
Journal:  Dis Markers       Date:  2019-10-07       Impact factor: 3.434

5.  Assessment of Sclerostin and Interleukin 6 Levels and Selected Anthropometric Parameters in Patients Receiving Hemodialysis Replacement Therapy-Pilot Study.

Authors:  Agnieszka Turon-Skrzypinska; Grazyna Dutkiewicz; Malgorzata Marchelek-Mysliwiec; Violetta Dziedziejko; Kazimierz Ciechanowski; Aleksandra Ryl; Iwona Rotter
Journal:  Medicina (Kaunas)       Date:  2019-12-15       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.